Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV (Q24246431)

1

0 references

Warren T Phipps

2

0 references

Gail E Kennedy

3

0 references

George Rutherford

Cochrane Database of Systematic Reviews

4

0 references

publication date

20 July 2005

0 references

published in

0 references

cites work

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Systematic Reviews in Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Primary prophylaxis for cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994--1998: regional variation and temporal trends

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

The hidden danger of primary fluconazole prophylaxis for patients with AIDS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Low-dose fluconazole as primary prophylaxis for cryptococcal infection in AIDS patients with CD4 cell counts of < or = 100/mm3: demonstration of efficacy in a positive, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Opportunistic infections occurring during highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021

Fluconazole for Primary Prophylaxis of AIDS-associated Cryptococcosis: A Case-control Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004773.PUB2

7 January 2021